Neuroene Therapeutics - News

Neuroene Therapeutics

Home
Contact
News
Investors
DATA AND PUBLICATIONS

Home
Contact
News
Investors
DATA AND PUBLICATIONS

Neuroene selected by CED to present on the main stage at the CED Life Science Conference in Raleigh this February 26-27

1/22/2019

https://cednc.org/events/ced-life-science-conference-companies

EurekAlert: Neuroene Therapeutics awarded $1.5 million to develop anti-seizure compound for epilepsy

10/31/2018

https://www.eurekalert.org/pub_releases/2018-10/muos-nta102918.php

Selection of Neuroene Therapeutics as an Early-Stage presenting company at the SEBIO Investor Forum in Atlanta

10/11/2018

https://www.southeastbio.org/presenting-companies-2018/

Neuroene Therapeutics awarded NIH Phase II SBIR

8/18/2018

https://projectreporter.nih.gov/project_info_description.cfm?aid=9558194&icde=40805181

SCRA/FRD pilot grant awarded for Parkinson's Disease study

6/25/2018

Invited pitch presentation at NISBRE 2018

6/23/2018

For the "Entrepreneurship: turning your innovative ideas into a marketable product" workshop.

Patent issued

1/9/2018

Compositions and methods for treating neurological diseases or injury. Issued on January 9, 2018
https://patents.google.com/patent/US9861596B2/en

Charleston Angel Conference - Pitch

9/20/2017

http://www.charlestonangelconference.com/agenda

Notice of Allowance received from U.S. Patent and Trademark Office for "Compositions And Methods For Treating Neurological Diseases Or Injury"

9/14/2017

Oral presentation at the Environmental Mutagenesis & Genomics Society meeting in Raleigh, NC

9/9/2017

www.emgs-us.org/page/saturday-agenda

Author

Write something about yourself. No need to be fancy, just an overview.

Archives

October 2018
August 2018
June 2018
January 2018
September 2017
June 2017
April 2017
March 2017
November 2016
August 2016
July 2016
November 2015

Categories

Powered by

Create your own unique website with customizable templates.